Jenni Kublbeck

Project Researcher , A.I. Virtanen Institute for Molecular Sciences

Ocular Drug Delivery group (ODD)

The Ocular Drug Delivery (ODD) group develops advanced drug delivery methods for targeted and prolonged drug delivery to both the anterior and posterior segments of the eye. Furthermore, we use computational tools for drug development and preclinical-to-clinical translation to build a quantitativ...

Mobilising Populism

Populist parties have succeeded in the elections both in Finland, in Europe and globally. As a result of political popularity the scientific community has become interested in populism, producing diverse research on its causes and consequences. Inspired by previous research we aim to build a soci...

Molecular Genetics of Alzheimer's Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the world, which affects up to 50% of individuals above the age of 85. Due to the global increase in the aging population, early diagnosis and treatment of AD are becoming increasingly important, not only from a human point...

Looking for creative solutions and strategies at municipal level

01.08.2020 - 31.12.2021
The starting point of the research is the concept of shrinking rural area as a multidimensional phenomenon. In areas with declining and ageing populations, the conditions for increased vitality, new opportunities and well-being are approached by applying smart shrinking concept. It is obvious tha...

RELOCAL - Resituating the Local in Cohesion and Territorial Development

01.10.2016 - 30.09.2020
See the project website at: https://relocal.eu/

The EU Horizon 2020 research project ‘Resituating the local in cohesion and territorial development’ – RELOCAL has received funding from European Union's Horizon 2020 research and innovation programme under Grant Agreement Nº 727097. ...

Timo Kumlin

Coordinator , Department of Environmental and Biological Sciences

Redox signaling (Anna-Liisa Levonen group)

Nrf2 is a transcription factor mainly involved in combating cellular stress caused by reactive oxygen and nitrogen species. However, Nrf2 is also involved in cancer and cardiometabolic diseases, making it an essential drug target.